Cincinnati Children’s Hospital Medical Center

Cincinnati Children’s Hospital Investigators Develop PERSEVERE to Predict Mortality Levels from Sepsis

Nov 19, 2019 | Assay, Biomarker, Cincinnati Children’s Hospital Medical Center, Precision Medicine, Sepsis

Cincinnati Children’s Hospital Medical Center investigators have developed a new rapid blood assay that can predict mortality risk levels from sepsis and could help inform precision medicine to treat the infections. They have filed patents through the institution’s...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

Cincinnati Children’s Hospital Investigators Develop PERSEVERE to Predict Mortality Levels from Sepsis

Pin It on Pinterest